Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine

The development of SARS-CoV-2 vaccines has raised several concerns regarding venous thromboembolism, namely cerebral venous thrombosis. Although cerebral venous thrombosis has been reported after administration of a viral vector vaccine, due to a possible auto-immune mechanism inducing thrombocytope...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Leonor, Soares-dos-Reis, Ricardo, Meira, João, Ferrão, Diana, Soares, Pedro Ribeirinho, Pastor, Ana, Gama, Guilherme, Fonseca, Luísa, Fagundes, Vítor, Carvalho, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148614/
https://www.ncbi.nlm.nih.gov/pubmed/34111775
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148614/
https://www.ncbi.nlm.nih.gov/pubmed/34111775
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105906

Ejemplares similares